It has been shown that the well-known modifier of CF lung disease, Mucin 4 (MUC4) and Mucin 5AC (MUC5AC) are associated with lung cancer risk and prognosis, respectively [11,59,60]. This evidence concerns the gene MUC5AC and lung carcinoma.